Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)

NCT00304278 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Erlotinib (Tarceva)
DRUG: Intra-arterial Cisplatin (PLAT)
RADIATION: Radiation Therapy (RAD)

Sponsor

Southern Illinois University

Collaborators

[object Object]
[object Object]